Micro-RNA378a-3p Induces Apoptosis in Sarcomatoid Renal Cell Carcinoma and Regulates POLR2A and RUNX2 Expression

Wen-Hui Weng1, Kai-Jie Yu2,3, Ju-Wen Jhan2

  • 1Department of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei, Taiwan, R.O.C.; wendywwh@ntut.edu.tw.

Anticancer Research
|January 30, 2022
PubMed
Abstract

Insights

MicroRNA-378 (miR-378) inhibits POLR2A and RUNX2 gene expression in sarcomatoid renal cell carcinoma (sRCC), promoting cancer cell apoptosis. This finding offers potential therapeutic targets for aggressive sRCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Sarcomatoid renal cell carcinoma (sRCC) is an aggressive cancer subtype.
  • The roles of POLR2A and RUNX2 genes in RCC and their association with miR-378 remain unclear.

Purpose of the Study:

  • Investigate the involvement of POLR2A and RUNX2 in RCC signaling pathways.
  • Determine the association between POLR2A, RUNX2, and miR-378 in sRCC.
  • Explore the therapeutic potential of targeting these molecules in sRCC.

Main Methods:

  • Analyzed 13 formalin-fixed, paraffin-embedded RCC samples.
  • Utilized software to predict miR-378 gene regulation in RCC.
  • Performed immunohistochemistry, Western Blotting, and flow cytometry on RCC cell lines and samples.
  • Conducted microRNA-378 transfection experiments.

Main Results:

  • POLR2A and RUNX2 mRNA and protein levels were significantly higher in sRCC compared to other RCC subtypes.
  • Overexpression of miR-378 significantly suppressed POLR2A and RUNX2 expression in sRCC cells.
  • miR-378 overexpression enhanced apoptosis in sRCC cells.

Conclusions:

  • miR-378 inhibits POLR2A and RUNX2 expression in sRCC, promoting apoptosis.
  • The observed apoptosis mechanism in sRCC may involve ERK2 and PI3K/AKT pathways.
  • These findings suggest miR-378 as a potential therapeutic target for sRCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K